Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Industry Watch.
Press releases published on April 2, 2025
AscellaHealth Releases Q1 2025 Specialty & Rare Pipeline Digest™ Providing Essential Clinical Drug Updates
GlobeNewswire
·
April 2, 2025
BERWYN, Pa., April 02, 2025 (GLOBE NEWSWIRE) -- AscellaHealth, a global partner delivering customizable solutions to support the specialty pharmaceutical industry, today unveiled its latest Specialty …
HALLE BERRY, CVS HEALTH AND TAMSEN FADAL AWARDEES OF WISEPAUSE WELLNESS AT ITS 10TH SUMMIT ON APRIL 12, 2025
EIN Presswire
·
April 2, 2025
WISEPAUSE EMPOWERS WOMEN WITH MENOPAUSE SUPPORT LOS ANGELES, CA, UNITED STATES, April 1, 2025 /EINPresswire.com/ -- WisePause Wellness, the nation’s premier menopause and midlife health event, announces its 10th Summit, taking place on Saturday, April …
Sienna Senior Living Completes Previously Announced Acquisitions in Alberta and British Columbia
GlobeNewswire
·
April 2, 2025
MARKHAM, Ontario, April 02, 2025 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. ("Sienna" or the "Company") (TSX: SIA) announced today that it has finalized its previously announced acquisition of a portfolio of four continuing care homes in Alberta (" …
Polyrizon Engages Leading Branding Firm for Strategic Brand Development
GlobeNewswire
·
April 2, 2025
Raanana, Israel, April 02, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ), a biotech company specializing in innovative intranasal hydrogels, today announced that it has entered into an agreement with a globally recognized branding and trademark …
Nice Healthcare Partners with Business Health Trust to Expand in Washington
GlobeNewswire
·
April 2, 2025
MINNEAPOLIS, April 02, 2025 (GLOBE NEWSWIRE) -- Employers know that offering the right benefits isn’t just about staying competitive—it’s about ensuring their employees have access to the care they need. Nice Healthcare, the clinic that comes to you, is …
Hint Health Announces Hint Summit 2025 at RosettaFest, Uniting DPC with the Future of Healthcare
GlobeNewswire
·
April 2, 2025
SAN FRANCISCO, Calif, April 02, 2025 (GLOBE NEWSWIRE) -- Hint Summit is back—and more connected than ever! This year, Hint Health is taking its flagship event to the next level, bringing Hint Summit 2025 to RosettaFest August 24-27 at the Colorado …
Hydreight Technologies Named One of the Americas’ Fastest Growing Companies by Financial Times
GlobeNewswire
·
April 2, 2025
VANCOUVER, British Columbia and LAS VEGAS, April 02, 2025 (GLOBE NEWSWIRE) -- Hydreight Technologies Inc. (TSXV: NURS) (OTCQB: HYDTF) (FSE: SO6), a fast-growing digital health platform transforming mobile and telehealth services in the U.S., has been named …
Prime Biome Reviews DON’T SKIP UNTIL SEE THIS for Preventing Fraud and Guaranteeing Reliability!
GlobeNewswire
·
April 2, 2025
ST. PETERSBURG, Fla., April 02, 2025 (GLOBE NEWSWIRE) -- 2025, a popular supplement for reviving the gut and skin micro biota, Prime Biome has swept the wellness industry. Prime Biome is the greatest option for safe, healthy skin out of all the products …
Oncocyte to Participate in 24th Annual Needham Virtual Healthcare Conference
GlobeNewswire
·
April 2, 2025
IRVINE, Calif., April 02, 2025 (GLOBE NEWSWIRE) -- Oncocyte Corp. (Nasdaq: OCX), a leading diagnostics technology company, today announced that Chief Executive Officer Josh Riggs and Chief Financial Officer Andrea James will attend the 24th Annual Needham …
Alpha Tau Receives FDA Approval to Initiate a Trial for Patients with Recurrent Glioblastoma
GlobeNewswire
·
April 2, 2025
JERUSALEM, April 02, 2025 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT®, announced today that the FDA has approved an Investigational Device Exemption (IDE) …
Nexalin Technology Enrolls First Patients and Advances Toward Treatment in UCSD Clinical Trial
GlobeNewswire
·
April 2, 2025
HOUSTON, TX, April 02, 2025 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”) the leader in Deep Intracranial Frequency Stimulation (DIFS™) of the brain, today announced that it has successfully enrolled the …
FibroBiologics Announces Scientific Advancement in Confirmation Results of Brain Tissue Repair
GlobeNewswire
·
April 2, 2025
HOUSTON, April 02, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) ("FibroBiologics”), a clinical-stage biotechnology company with 240+ patents issued and pending for the development of therapeutics and potential cures for chronic diseases …
CorMedix Inc. to Participate in the 24th Annual Needham Virtual Healthcare Conference
GlobeNewswire
·
April 2, 2025
BERKELEY HEIGHTS, N.J., April 02, 2025 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announced that …
Caretaker Medical Receives Inaugural Healthcare Tech Innovation Award and $200,000 Grant from Medical Society of D.C.
EIN Presswire
·
April 2, 2025
WASHINGTON, DC, UNITED STATES, April 1, 2025 /EINPresswire.com/ -- Caretaker Medical is honored to announce it has been awarded the Healthcare Technology Innovation Award, along with a $200,000 grant, from the Medical Society of the District of Columbia …
Appili President and CEO, Don Cilla to Join Aditxt CEO, Amro Albanna for Aditxt Weekly Update on April 4, 2025
GlobeNewswire
·
April 2, 2025
Event exploring the escalating threat of emerging infectious diseases Discussion covering going-private transaction with Aditxt, strategic growth partner HALIFAX, Nova Scotia, April 02, 2025 (GLOBE NEWSWIRE) -- Appili Therapeutics Inc. (TSX: APLI; OTCPink: …
Organovo Provides Update on Cash and Nasdaq Continued Listing Requirements
GlobeNewswire
·
April 2, 2025
SAN DIEGO, April 02, 2025 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO) (“Organovo” or the “Company”), a clinical stage biotechnology company focused on developing novel treatment approaches in inflammatory bowel disease (IBD), today reported …
Denali Therapeutics Announces Initiation of BLA Filing for Accelerated Approval of Tividenofusp Alfa for the Treatment of Hunter Syndrome (MPS II) and Positive Ongoing Interactions with FDA on DNL126 Through START Program
GlobeNewswire
·
April 2, 2025
Rolling submission of BLA initiated for tividenofusp alfa; preparations ongoing for potential U.S. commercial launch in late 2025 or early 2026 Alignment through recent interactions with CDER on path to accelerated approval and conversion to full approval …
Startup Care Exhibition Puts Carers and Clients at the Heart of the Conversation
EIN Presswire
·
April 2, 2025
LONDON, KENT, UNITED KINGDOM, April 2, 2025 /EINPresswire.com/ -- Startup Care has announced that its upcoming exhibition will prioritise the voices of carers and private care clients, ensuring their lived experiences are central to the event’s …
Immunocore to present at upcoming investor conferences
GlobeNewswire
·
April 2, 2025
Immunocore to present at upcoming investor conferences (OXFORDSHIRE, England …
Akoya Biosciences and Team SAMBAI Announce Selection of the PhenoCycler®-Fusion as the Foundational Spatial Proteomics Technology for Large-Scale Study to Address Cancer Inequities
GlobeNewswire
·
April 2, 2025
Akoya’s technology to generate data for a first-of-its-kind Biobank and Data Repository for Cancer Equity Research, funded through the Cancer Grand Challenges initiative The unprecedented scale of the initiative requires the high plex and high throughput …